Cargando…
c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia
Acute myeloid leukemia (AML) often requires long-term intensive chemotherapy for its cure. During chemotherapy, the patient always experiences neutropenia with readings below 500 cells/μL; this is often accompanied by pyrexia with a temperature of more than 101°F. This combination of neutropenia and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929597/ https://www.ncbi.nlm.nih.gov/pubmed/35298471 http://dx.doi.org/10.1371/journal.pone.0263623 |
_version_ | 1784670892860637184 |
---|---|
author | Kubo, Hiroyuki Imataki, Osamu Kubo, Yukiko Hamasaki Uemura, Makiko |
author_facet | Kubo, Hiroyuki Imataki, Osamu Kubo, Yukiko Hamasaki Uemura, Makiko |
author_sort | Kubo, Hiroyuki |
collection | PubMed |
description | Acute myeloid leukemia (AML) often requires long-term intensive chemotherapy for its cure. During chemotherapy, the patient always experiences neutropenia with readings below 500 cells/μL; this is often accompanied by pyrexia with a temperature of more than 101°F. This combination of neutropenia and fever is called febrile neutropenia (FN). A tool to sum up the daily severity of a patient’s neutropenia, the “D-index,” has been validated in some specific clinical settings. In this study, we examined whether the D-index is a useful predictor of the onset of FN. We recruited consecutive patients treated with induction and consolidation chemotherapy for newly diagnosed AML. We gathered all the FN events and their clinical background data retrospectively. Patients’ background, such as pre-existing conditions and disease status before the treatment, were analyzed using multivariate methods. All FN events during chemotherapy were evaluated for infection focus and causative organism. A total cohort of 51 cases (25 women, 26 men; median age 51 years, range 18–74) was analyzed. They displayed 171 neutropenic events (115 FN and 56 afebrile episodes) during chemotherapy, and complete neutropenic events were used in this study. Sensitivity and specificity analysis showed that the most useful cutoff value to predict the onset of FN was a cumulative D-index at day 11 (c-D11-index) of 718. The cumulative incidence of FN during chemotherapy was significantly higher in the group with c-D11-index ≥710 (80%) than in the group with c-D11-index <710 (39%) (P < 0.0001). Through multivariate analysis, the presence of diabetes mellitus and the c-D11-index were extracted as contributing factors to the onset of FN (P = 0.0087 and 0.0002, respectively). In conclusion, we can predict that AML patients receiving chemotherapy will experience the complication of FN when the c-D-index at day 11 is >710, with an odds ratio of 2.1. |
format | Online Article Text |
id | pubmed-8929597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89295972022-03-18 c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia Kubo, Hiroyuki Imataki, Osamu Kubo, Yukiko Hamasaki Uemura, Makiko PLoS One Research Article Acute myeloid leukemia (AML) often requires long-term intensive chemotherapy for its cure. During chemotherapy, the patient always experiences neutropenia with readings below 500 cells/μL; this is often accompanied by pyrexia with a temperature of more than 101°F. This combination of neutropenia and fever is called febrile neutropenia (FN). A tool to sum up the daily severity of a patient’s neutropenia, the “D-index,” has been validated in some specific clinical settings. In this study, we examined whether the D-index is a useful predictor of the onset of FN. We recruited consecutive patients treated with induction and consolidation chemotherapy for newly diagnosed AML. We gathered all the FN events and their clinical background data retrospectively. Patients’ background, such as pre-existing conditions and disease status before the treatment, were analyzed using multivariate methods. All FN events during chemotherapy were evaluated for infection focus and causative organism. A total cohort of 51 cases (25 women, 26 men; median age 51 years, range 18–74) was analyzed. They displayed 171 neutropenic events (115 FN and 56 afebrile episodes) during chemotherapy, and complete neutropenic events were used in this study. Sensitivity and specificity analysis showed that the most useful cutoff value to predict the onset of FN was a cumulative D-index at day 11 (c-D11-index) of 718. The cumulative incidence of FN during chemotherapy was significantly higher in the group with c-D11-index ≥710 (80%) than in the group with c-D11-index <710 (39%) (P < 0.0001). Through multivariate analysis, the presence of diabetes mellitus and the c-D11-index were extracted as contributing factors to the onset of FN (P = 0.0087 and 0.0002, respectively). In conclusion, we can predict that AML patients receiving chemotherapy will experience the complication of FN when the c-D-index at day 11 is >710, with an odds ratio of 2.1. Public Library of Science 2022-03-17 /pmc/articles/PMC8929597/ /pubmed/35298471 http://dx.doi.org/10.1371/journal.pone.0263623 Text en © 2022 Kubo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kubo, Hiroyuki Imataki, Osamu Kubo, Yukiko Hamasaki Uemura, Makiko c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title | c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title_full | c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title_fullStr | c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title_full_unstemmed | c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title_short | c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
title_sort | c-d-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929597/ https://www.ncbi.nlm.nih.gov/pubmed/35298471 http://dx.doi.org/10.1371/journal.pone.0263623 |
work_keys_str_mv | AT kubohiroyuki cdindexatday11canpredictfebrileneutropeniaduringchemotherapyinacutemyeloidleukemia AT imatakiosamu cdindexatday11canpredictfebrileneutropeniaduringchemotherapyinacutemyeloidleukemia AT kuboyukikohamasaki cdindexatday11canpredictfebrileneutropeniaduringchemotherapyinacutemyeloidleukemia AT uemuramakiko cdindexatday11canpredictfebrileneutropeniaduringchemotherapyinacutemyeloidleukemia |